K. Nishiya et al., ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS IS UNRELATED TO CLINICAL-FEATURES, Clinical rheumatology, 16(1), 1997, pp. 70-75
To investigate the incidence, the specificity and clinical significanc
e of positivity for serum anti-neutrophil cytoplasmic antibody (ANCA)
in 31 patients with systemic lupus erythematosus (SLE), the indirect i
mmunofluorescence (IIF) technique and enzyme-linked immunosorbent assa
y (ELISA) were used to measure ANCA, Purified myeloperoxidase (MPO), l
actoferrin (LF), cathepsin-G (CTG) and elastase (HLE) served as ANCA a
ntigens for ELISA. Thirteen (42%) of the 31 SLE patients showed positi
vity for perinuclear, but not cytoplasmic, ANCA by IIF. Five of 31 ser
a were positive for MPO, 10 for LF, 1 for CTG and 0 for HLE by ELISA.
Patients positive for ANCA had a higher score of SLE disease activity
index (SLEDAI) than those without ANCA. There was no correlation bet s
een ANCA positivity, clinical manifestations, or organic involvement,
While the ANCA in patients with SLE reflected disease activity, it was
unrelated to organic involvement.